Juvederm Voluma with Lido (2x1 ml)

This treatment is strictly contraindicated. No clinical safety data exists for Vycross HA injectables during pregnancy. We defer elective aesthetic procedures until after childbirth to ensure the highest safety standards.

Injection is not recommended for nursing mothers. It is advised to wait until the breastfeeding period has completely concluded before undergoing elective volumizing treatments.

Dosage is individualized based on the level of volume deficit and anatomical structure. A typical cheek rejuvenation session requires 1 ml to 2 ml per side. For chin augmentation, 1 ml is often the starting point. Practitioners should assess if subtle structural support is achieved before utilizing the full density of Voluma for high-projection goals.

Common reactions include temporary swelling, tenderness, and potential purple bruising at the deep injection site. Because Vycross technology binds less water, initial edema is generally lower than with Hylacross gels. Follow our expert aftercare guide for optimal recovery. Any persistent blanching requires immediate evaluation per our vascular occlusion protocol.

Voluma acts as a robust mechanical scaffold in the deep dermis or supraperiosteal layer. The tightly cross-linked HA matrix resists enzymatic degradation and compression from facial movement. Unlike superficial skin boosters, Voluma provides significant G-prime to physically lift sagging tissue and restore youthful contours.

The formulation contains 20 mg/ml of cross-linked Hyaluronic Acid of non-animal origin and 0.3% Lidocaine hydrochloride.

Patients should avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator that can increase post-filler swelling and worsen bruising at the deep entry points required for mid-face contouring.